109 related articles for article (PubMed ID: 38723823)
1. Based on polydopamine-coated metal organic framework multifunctional nanoplatform for enhanced photothermal/sonodynamicand treatment combined with checkpoint blockade therapy.
Bai Z; Huang J; Lu H; Wang N; Li H; Zhu Y
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132207. PubMed ID: 38723823
[TBL] [Abstract][Full Text] [Related]
2. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
4. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
5. A copper-metal organic framework enhances the photothermal and chemodynamic properties of polydopamine for melanoma therapy.
Liu L; Zhang H; Peng L; Wang D; Zhang Y; Yan B; Xie J; Xing S; Peng F; Liu X
Acta Biomater; 2023 Mar; 158():660-672. PubMed ID: 36640955
[TBL] [Abstract][Full Text] [Related]
6. Polydopamine Nanostructure-Enhanced Water Interaction with pH-Responsive Manganese Sulfide Nanoclusters for Tumor Magnetic Resonance Contrast Enhancement and Synergistic Ferroptosis-Photothermal Therapy.
Ma G; Zhang X; Zhao K; Zhang S; Ren K; Mu M; Wang C; Wang X; Liu H; Dong J; Sun X
ACS Nano; 2024 Jan; 18(4):3369-3381. PubMed ID: 38251846
[TBL] [Abstract][Full Text] [Related]
7. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
8. Superoxide Dismutase-Like Regulated Fe/Ppa@PDA/B for Synergistically Targeting Ferroptosis/Apoptosis to Enhance Anti-Tumor Efficacy.
Ding X; Wang Z; Yu Q; Michał N; Roman S; Liu Y; Peng N
Adv Healthc Mater; 2023 Nov; 12(29):e2301824. PubMed ID: 37485811
[TBL] [Abstract][Full Text] [Related]
9. A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects.
An G; Zheng H; Guo L; Huang J; Yang C; Bai Z; Wang N; Yang W; Zhu Y
J Colloid Interface Sci; 2024 May; 662():298-312. PubMed ID: 38354557
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
[TBL] [Abstract][Full Text] [Related]
11. Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy.
Ren Q; Yu N; Wang L; Wen M; Geng P; Jiang Q; Li M; Chen Z
J Colloid Interface Sci; 2022 May; 614():147-159. PubMed ID: 35091144
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
[TBL] [Abstract][Full Text] [Related]
13. Remodeling the Tumor Microenvironment with Core-Shell Nanosensitizer Featuring Dual-Modal Imaging and Multimodal Therapy for Breast Cancer.
Hou YK; Zhang ZJ; Li RT; Peng J; Chen SY; Yue YR; Zhang WH; Sun B; Chen JX; Zhou Q
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2602-2616. PubMed ID: 36622638
[TBL] [Abstract][Full Text] [Related]
14. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
15. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis.
Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q
ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091
[TBL] [Abstract][Full Text] [Related]
16. Redox-Channeling Polydopamine-Ferrocene (PDA-Fc) Coating To Confer Context-Dependent and Photothermal Antimicrobial Activities.
Song J; Liu H; Lei M; Tan H; Chen Z; Antoshin A; Payne GF; Qu X; Liu C
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8915-8928. PubMed ID: 31971763
[TBL] [Abstract][Full Text] [Related]
17. PEGylated chitosan-coated nanophotosensitizers for effective cancer treatment by photothermal-photodynamic therapy combined with glutathione depletion.
Chen YH; Liu IJ; Lin TC; Tsai MC; Hu SH; Hsu TC; Wu YT; Tzang BS; Chiang WH
Int J Biol Macromol; 2024 May; 266(Pt 2):131359. PubMed ID: 38580018
[TBL] [Abstract][Full Text] [Related]
18. Endogenous H
Du JR; Teng DK; Wang Y; Wang Q; Lin YQ; Luo Q; Xue JN; Zhu LY; Dong P; Zhang GM; Liu Y; Sun ZX; Wang H; Sui GQ
Int J Nanomedicine; 2023; 18():6667-6687. PubMed ID: 38026520
[TBL] [Abstract][Full Text] [Related]
19. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
[TBL] [Abstract][Full Text] [Related]
20. Covalent Organic Framework-Based Nanocomposite for Synergetic Photo-, Chemodynamic-, and Immunotherapies.
Liu S; Zhou Y; Hu C; Cai L; Pang M
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43456-43465. PubMed ID: 32880166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
